Human challenge trials to assess the efficacy of currently approved COVID-19 vaccines against SARS-CoV-2 variants
Saved in:
| Main Authors: | Shan Su, Yiming Shao, Shibo Jiang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2021-01-01
|
| Series: | Emerging Microbes and Infections |
| Online Access: | https://www.tandfonline.com/doi/10.1080/22221751.2021.1896956 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Timely development of vaccines against SARS-CoV-2
by: Shan Lu
Published: (2020-01-01) -
An Update on Anti-COVID-19 Vaccines and the Challenges to Protect Against New SARS-CoV-2 Variants
by: Fábio Mambelli, et al.
Published: (2025-01-01) -
Beyond the Pandemic Era: Recent Advances and Efficacy of SARS-CoV-2 Vaccines Against Emerging Variants of Concern
by: Ankita Saha, et al.
Published: (2025-04-01) -
New Trends in SARS-CoV-2 Variants and Vaccines
by: Seik-Soon Khor
Published: (2025-03-01) -
A multi-antigen-based SARS-CoV-2 vaccine provides higher immune responses and protection against SARS-CoV-2 variants
by: Marwa Alhashimi, et al.
Published: (2025-07-01)